PVP Ventures Issues Corrigendum on Dr. Neeraja Nagarajan's Appointment as Additional Director and COO
PVP Ventures Limited issued a corrigendum on 15th May 2026 to its Board Meeting outcome of the same date, revising the effective date of Dr. Neeraja Nagarajan's appointment as Additional Director and Chief Operating Officer (COO) from 15th May 2026 to 01st July 2026. All other details from the original Board Meeting outcome remain unchanged. The corrigendum was signed by Chairman and Managing Director Prasad V Potluri.

*this image is generated using AI for illustrative purposes only.
pvp ventures Limited has issued a corrigendum to the outcome of its Board Meeting held on 15th May 2026, correcting the effective date of Dr. Neeraja Nagarajan's appointment as Additional Director and Chief Operating Officer (COO) of the Company.
Correction to Appointment Date
In the original Board Meeting outcome submitted on 15th May 2026, it was stated that Dr. Neeraja Nagarajan's appointment as Additional Director and COO would take effect from 15th May 2026. The Company has now clarified that Dr. Neeraja Nagarajan shall assume office as Additional Director and Chief Operating Officer with effect from 01st July 2026.
The key details of the corrigendum are summarised below:
| Parameter: | Details |
|---|---|
| Name: | Dr. Neeraja Nagarajan |
| Designation: | Additional Director and Chief Operating Officer (COO) |
| Original Effective Date (as stated): | 15th May 2026 |
| Revised Effective Date: | 01st July 2026 |
| Board Meeting Reference Date: | 15th May 2026 |
Other Details Remain Unchanged
PVP Ventures confirmed that all other details contained in the original Board Meeting outcome remain unchanged. The corrigendum was signed by Prasad V Potluri, Chairman and Managing Director of PVP Ventures Limited, on 15th May 2026.
Historical Stock Returns for PVP Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.78% | -14.94% | -21.98% | -22.18% | +11.68% | +370.43% |
How might Dr. Neeraja Nagarajan's delayed assumption of the COO role on July 1st impact PVP Ventures' ongoing operational decisions and strategic initiatives during the interim period?
What specific operational or strategic priorities is Dr. Neeraja Nagarajan expected to focus on once she officially takes charge as COO of PVP Ventures?
Could the revised appointment date signal any underlying organizational or regulatory considerations that investors should monitor at PVP Ventures?


































